The ICER has released a scoping document that will compare the clinical effectiveness and value of multiple CAR-T cell treatments under review by the FDA. READ MORE

Research in Review

Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to research presented at the 2016 ASH Annual Meeting and Exposition.